Ras Al Khaimah is set to host the inaugural Biotechnology Conference in 2026, a significant event aimed at fostering collaboration between researchers and investors in the vital sector. This conference will serve as a platform for exchanging innovative ideas in the field of life sciences.
Eli Lilly and Company has announced its agreement to acquire Kilonia Therapeutics, a company specializing in gene delivery technologies, in a deal valued at $7 billion. This move aims to enhance Eli Lilly's capabilities in the field of genetic therapies.
Anthropic has announced its acquisition of the biotech startup Cohere Bio in a deal valued at <strong>$400 million</strong>. This acquisition aims to enhance Anthropic's capabilities in artificial intelligence and biotechnology.
Chinese scientists have unveiled genetically modified plants capable of glowing in the dark, potentially revolutionizing urban lighting, tourism, and sustainable design. These plants were developed using gene editing techniques to transfer luminous genes from fireflies and bioluminescent fungi into plant cells.
Russian biotechnology expert Alexey Sturgin has revealed the potential for human life expectancy to rise to 100 years in the near future, citing several key factors necessary to achieve this goal. Advances in medical science and public health are pivotal to this change.
A team of scientists has achieved a groundbreaking scientific feat by transferring a complete genome from a living bacteria to a dead one, successfully bringing it back to life. This unprecedented achievement in synthetic biology opens new avenues for understanding biological processes and genetic engineering possibilities.
A group of billionaires worldwide is investing in a biotechnology company focused on producing genetically modified monkey organs, paving the way for the potential creation of human organs in laboratories. This initiative could revolutionize the future of organ transplantation.